Lifesaving HIV treatment could reach millions more people following landmark study

Millions more people could get access to life-saving HIV drug therapy, following a landmark study led by Australian researchers based at the Kirby Institute at the University of New South Wales (UNSW).

The researchers have found a lower daily dose of an important HIV drug therapy is safe and as effective in suppressing the virus as the standard recommended dose.

The findings have been presented at the International AIDS Society Conference in Kuala Lumpur, Malaysia.

"This has the potential to affect the treatment of millions of HIV positive people," says UNSW Professor Sean Emery, the protocol chairperson of the study, known as ENCORE1 and Head of the Therapeutic and Vaccine Research Program at the Kirby Institute.

"A reduced daily dose should translate into a lower cost of treatment and permit more effective and efficient use of . Essentially, more people could receive this life-saving treatment for the same amount of funding."

HIV-positive people from 13 countries in Africa, Asia, Australia, Europe and Latin America took part in the trial. Half these people took two-thirds of the current standard daily dose of the antiretroviral (ART) efavirenz, a commonly used treatment for HIV; the other half took the standard daily dose. The 630 participants were observed regularly for a year. The results indicate that a reduction in daily dose of one third is both safe and effective compared to the higher dose currently recommended for people with HIV infection.

add to favorites email to friend print save as pdf

Related Stories

UN urges Asia to ditch punitive laws to fight AIDS (Update)

Jul 01, 2013

(AP)—U.N. health officials urged Asian governments Monday to get rid of what they say are punitive laws that hinder the battle against HIV and AIDS by discriminating against high-risk groups and deterring them from seeking ...

Food insecurity linked to HIV-treated drug users' deaths

May 31, 2013

Food insecurity increases the risk of death among injection drug users living with HIV/AIDS even when they are receiving life-prolonging antiretroviral therapy (ART), according to a new study involving Simon Fraser University.

Recommended for you

A fresh setback for efforts to cure HIV infection

11 hours ago

Researchers are reporting another disappointment for efforts to cure infection with the AIDS virus. Six patients given blood-cell transplants similar to one that cured a man known as "the Berlin patient" have ...

Cambodia village reports mass HIV/AIDS infection

Dec 16, 2014

Cambodian health authorities on Tuesday said more than 80 people—including children and the elderly—who tested positive for HIV/AIDS in a single remote village may have been infected by contaminated needles.

Occasional heroin use may worsen HIV infection

Dec 15, 2014

Researchers at Yale and Boston University and their Russian collaborators have found that occasional heroin use by HIV-positive patients may be particularly harmful to the immune system and worsens HIV disease, compared to ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.